Parathyroid function and cardiovascular remodeling in arterial hypertension patients
Abstract
Aim. To investigate structure and function of left ventriculum (LV) and brachial artery (BA) in arterial hypertension (AH) patients, according to blood levels of parathyroid hormone (PTH).
Material and methods. In total, 95 untreated patients with Stage I-III AH were examined. Blood PTH, total calcium levels, and 24-hour urine calcium excretion were measured. All participants underwent Doppler echocardiography, 24-hour blood pressure monitoring (BPM), and BA ultrasound. According to PTH levels, the patients were divided into three groups: Group I – 0-25 pg/ml, Group II – 26-50 pg/ml, and Group III – 51 pg/ml.
Results. LV hypertrophy prevalence in Group III was 80,6%, in Group I – 43,7%. In “dippers” (24-hour BPM data), PTH level and 24-hour urine calcium excretion were 1,5 times lower than in “non-dippers”. Comparing to Group I, Group III demonstrated significantly greater intima-media thickness (+17,8%) and linear blood flow
velocity (+19,7%), but lower BA diameter (417,3%) and endothelium-dependent vasodilatation (415,5%).
Conclusion. PTH levels correlated with prevalence and severity of LV and BA remodeling.
About the Authors
B. G. Iskenderov
Penza Institute of Continuous Medical Education. Penza
Russian Federation
Russian Federation
L. F. Burmistrova
Penza Institute of Continuous Medical Education. Penza
Russian Federation
Russian Federation
T. V. Lokhina
Penza Institute of Continuous Medical Education. Penza
Russian Federation
Russian Federation
G. N. Abramova
Penza Institute of Continuous Medical Education. Penza
Russian Federation
Russian Federation
N. A. Timofeeva
Penza Institute of Continuous Medical Education. Penza
Russian Federation
Russian Federation
T. M. Shibaeva
Penza Institute of Continuous Medical Education. Penza
Russian Federation
Russian Federation
References
1. Гогин Е.Е. Артериальная гипертензия. Состояние клеточных мембран и риск развития гипертонии. Москва «Медицина» 2003; 44-6.
2. Кушаковский М.С. Эссенциальная гипертония (гипертоническая болезнь). Причины, механизмы, клиника, лечение. СПб «Сотис» 2002.
3. Люсов В.А., Пальшина А.М. Исследование кальциевого обмена у больных артериальной гипертензией. РКЖ 1998; 1: 46-8.
4. Постнов Ю.В. К развитию мембранной концепции патогенеза первичной артериальной гипертензии. Физиолог ж 1988; 11: 1546-53.
5. Профилактика, диагностика и лечение артериальной гипертензии. Российские рекомендации. 2-й пересмотр. ВНОК, Секция артериальной гипертензии. Москва 2004; 38 с.
6. Титов В.Н. Методические и диагностические аспекты определения содержания кальция. Клин лаб диагн 1996; 2: 23-6.
7. Физиология и патофизиология сердца. Под ред. Н.Сперелакиса. Москва 1988; 2: 274-90.
8. Филимонов В.И. Руководство по общей и клинической физиологии. Москва «МИА» 2000; 287-90.
9. Abernethy DR, Schwartz JB. Drug therapy. Calcium-antagonist drugs. N Engl J Med 1999; 341: 1447-57.
10. Brown EM, Pollak M, Hebert CH. Sensing of extracellular Ca by parathyroid and kidney cells: Cloning and characterization of extracellular Ca-sensing receptor. Am J Kidney Dis 1995; 25: 506-13.
11. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
12. Devereux R, Reichek N. Echocardiographic assessment of left ventricular mass in man. Circulation 1977; 55: 613-8.
13. Endres DB, Villaneuva R, Sharp CFJr, Singer FR. Measurement of parathyroid hormone. Endocrinol Metab Clin North Am 1989; 18: 611-29.
14. Goodman WG, Veldhuis JD, Belin TR, et al. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism. Kidney Int 1997; 51: 1590-5.
15. Kao PC, van Heerden JA, Grant CS, Khosia S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc 1992; 67: 6374-5.
16. Pocotte SL, Ehrenstein G, Fitzpatrick LA. Regulation of parathyroid hormone secretion. Endocrin Rev 1991; 12: 291-301.
17. Popovtzer MM, Knochel JP, Kumar R. Disorders of calcium, phosphorus, vitamin D and parathyroid hormone activity. Renal and electrolyte disorders 1996; 34: 124-43.
Review
For citations:
Iskenderov B.G., Burmistrova L.F., Lokhina T.V., Abramova G.N., Timofeeva N.A., Shibaeva T.M. Parathyroid function and cardiovascular remodeling in arterial hypertension patients. Cardiovascular Therapy and Prevention. 2008;7(2):23-27. (In Russ.)
Views:
584
Email this article 
